{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:04:05Z","timestamp":1761948245982,"version":"build-2065373602"},"reference-count":41,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Science and Technology Development Plan of Shandong Province","award":["2014GSF118175"],"award-info":[{"award-number":["2014GSF118175"]}]},{"name":"Major Project of Science and Technolodgy of Shandong Province","award":["2015ZDJS04001"],"award-info":[{"award-number":["2015ZDJS04001"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.bmcl.2017.04.028","type":"journal-article","created":{"date-parts":[[2017,4,12]],"date-time":"2017-04-12T00:17:59Z","timestamp":1491956279000},"page":"2364-2368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Recent progress on the treatment of Ebola virus disease with Favipiravir and other related strategies"],"prefix":"10.1016","volume":"27","author":[{"given":"Tao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianbo","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2017.04.028_b0005","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1056\/NEJMoa1404505","volume":"371","author":"Baize","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmcl.2017.04.028_b0010","doi-asserted-by":"crossref","first-page":"4760","DOI":"10.3390\/v6114760","volume":"6","author":"Kuhn","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.bmcl.2017.04.028_b0015","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1056\/NEJMp1409903","volume":"371","author":"Frieden","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmcl.2017.04.028_b0020","unstructured":"World Health Organization. Ebola situation report-14 March, 2016.[EB\/OL].[2016-11-15] http:\/\/apps.who.int\/ebola\/current-situation\/ebola-situation-report-16-march-2016."},{"key":"10.1016\/j.bmcl.2017.04.028_b0025","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1126\/science.345.6195.364","volume":"345","author":"Enserink","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.bmcl.2017.04.028_b0030","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1128\/AAC.46.4.977-981.2002","volume":"46","author":"Furuta","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2017.04.028_b0035","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1073\/pnas.0909603107","volume":"107","author":"Kiso","year":"2010","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bmcl.2017.04.028_b0040","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1128\/AAC.00356-07","volume":"51","author":"Gowen","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2017.04.028_b0045","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1128\/AAC.01074-08","volume":"53","author":"Julander","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2017.04.028_b0050","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1017\/dmp.2014.151","volume":"9","author":"Nagata","year":"2015","journal-title":"Disaster Med Public Health Prep"},{"key":"10.1016\/j.bmcl.2017.04.028_b0055","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.antiviral.2014.01.012","volume":"104","author":"Smither","year":"2014","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmcl.2017.04.028_b0060","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.antiviral.2004.05.001","volume":"63","author":"G\u00fcnther","year":"2004","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmcl.2017.04.028_b0065","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1128\/AAC.46.4.977-981.2002","volume":"46","author":"Furuta","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2017.04.028_b0070","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.antiviral.2014.02.014","volume":"105","author":"Oestereich","year":"2014","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmcl.2017.04.028_b0075","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/AAC.49.3.981-986.2005","volume":"49","author":"Furuta","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2017.04.028_b0080","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1128\/AAC.00649-13","volume":"57","author":"Sangawa","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2017.04.028_b0085","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1021\/bi00008a014","volume":"34","author":"Isley","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmcl.2017.04.028_b0090","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1128\/AAC.01317-07","volume":"52","author":"McCown","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2017.04.028_b0095","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.sbi.2016.01.002","volume":"36","author":"Reguera","year":"2016","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/j.bmcl.2017.04.028_b0100","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.virol.2015.03.018","volume":"479\u2013480","author":"Ort\u00edn","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.bmcl.2017.04.028_b0105","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1099\/0022-1317-82-6-1365","volume":"82","author":"Bray","year":"2001","journal-title":"J Gen Virol"},{"key":"10.1016\/j.bmcl.2017.04.028_b0110","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1099\/jmm.0.036210-0","volume":"61","author":"Lever","year":"2012","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.bmcl.2017.04.028_b0115","doi-asserted-by":"crossref","first-page":"S364","DOI":"10.1086\/520613","volume":"196","author":"Rollin","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bmcl.2017.04.028_b0120","first-page":"1","volume":"13","author":"Sissoko","year":"2016","journal-title":"PLOS Med"},{"key":"10.1016\/j.bmcl.2017.04.028_b0125","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1093\/cid\/ciw571","volume":"63","author":"Bai","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bmcl.2017.04.028_b0130","unstructured":"World Health Organization. Clinical management of patients with viral haemorrhagic fever: a pocket guide for the front-line worker. 2014: March 30."},{"key":"10.1016\/j.bmcl.2017.04.028_b0135","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.antiviral.2009.02.198","volume":"82","author":"Furuta","year":"2009","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmcl.2017.04.028_b0140","unstructured":"Sakamoto K, Ohashi S., Yamazoe R. The inhibition of FMD virus excretion from the infected pigs by an antiviral agent, T-1105. FAO Report of the Research Group of the Standing Technical Committee of European Commission for the control of Foot-and-Mouth Disease, Paphos, Cyprus. 2006, FAO Appendix 64, 418\u2013424."},{"key":"10.1016\/j.bmcl.2017.04.028_b0145","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1093\/jac\/dku209","volume":"69","author":"Delang","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bmcl.2017.04.028_b0150","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1128\/AAC.01494-06","volume":"51","author":"Julander","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2017.04.028_b0155","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1146\/annurev-pharmtox-010716-105055","volume":"57","author":"Cardile","year":"2017","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.bmcl.2017.04.028_b0160","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.antiviral.2016.05.017","volume":"132","author":"Beck","year":"2016","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmcl.2017.04.028_b0165","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1128\/AAC.00543-16","volume":"60","author":"Anantpadma","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2017.04.028_b0170","doi-asserted-by":"crossref","first-page":"10982","DOI":"10.1128\/JVI.01490-15","volume":"89","author":"Davidson","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.bmcl.2017.04.028_b0175","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nature14442","volume":"521","author":"Thi","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2017.04.028_b0180","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/cid\/civ395","volume":"61","author":"Florescu","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bmcl.2017.04.028_b0185","unstructured":"News. China approves its first Ebola drug. 08-30-2014. [EB\/OL]http:\/\/english.cntv.vn\/2014\/08\/30\/VIDE1409370482655016.shtml."},{"key":"10.1016\/j.bmcl.2017.04.028_b0190","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature13027","volume":"508","author":"Warren","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2017.04.028_b0195","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/nm.3702","volume":"20","author":"Stanley","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.bmcl.2017.04.028_b0200","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJMc1505499","volume":"373","author":"Ledgerwood","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmcl.2017.04.028_b0205","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nm1258","volume":"11","author":"Jones","year":"2005","journal-title":"Nat Med"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X17304043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X17304043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:20:14Z","timestamp":1760772014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X17304043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0960894X17304043"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2017.04.028","relation":{},"ISSN":["0960-894X"],"issn-type":[{"type":"print","value":"0960-894X"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent progress on the treatment of Ebola virus disease with Favipiravir and other related strategies","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2017.04.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}